109162 ⎘
Structure or type of the nucleic acid; Chemical structure of the backbone Phosphorothioates
GNAQ targeted dsRNA compositions and methods for inhibiting expression
#3602Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules
#3603Modulation of immunostimulatory properties by small oligonucleotide-based compounds
#3604CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
#3605Immunostimulatory oligonucleotide multimers
#3606Pharmaceutical composition
#3607MODULATION OF SID-1 EXPRESSION
#3608RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3609OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA
#3610Oligoribonucleotides and uses thereof
#3611DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS
#3612Methods for treating hypercholesterolemia
#3613Modulation of factor 11 expression
#3614DOUBLE-STRANDED OLIGONUCLEOTIDES
#3615DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS
#3616Pure miRNA Sample Preparation Method
#3617Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
#3618METHODS AND IMMUNE MODULATOR NUCLEIC ACID COMPOSITIONS FOR PREVENTING AND TREATING DISEASE
#3619MODULATION OF eIF4E EXPRESSION
#3620Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions
#3621Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
#3622Compositions and methods for inhibiting expression of transthyretin
#3623Methods for treating multiple sclerosis using antisense oligonucleotides
#3624Modulation of HIF1-beta expression
#3625Therapeutic targets and molecules
#3626RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#3627RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
#3628Compositions and methods for gene silencing
#3629Inhibitor Nucleic Acids
#3630Oligomeric compounds for the modulation of HIF-1alpha expression
#3631COMPOUNDS AND METHODS FOR MODULATING PROTEIN EXPRESSION
#3632Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#3633NUCLEIC ACID COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH
#3634Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference
#3635Diagnosis and treatment of malignant neoplasms
#3636MODULATION OF MYELOID DIFFERENTATION PRIMARY RESPONSE GENE 88 (MYD88) EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES
#3637Spinal muscular atrophy (SMA) treatment via targeting of splice site inhibitory sequences
#3638Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
#3639METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION
#3640COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#3641Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alpha
#3642Oligonucleotides affecting expression of phosphodiesterases
#3643MODULATION OF TOLL-LIKE RECEPTOR 8 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES
#3644EFFICIENT REDUCTION OF TARGET RNA'S BY SINGLE- AND DOUBLE-STRANDED OLIGOMERIC COMPOUNDS
#3645Modified Oligonucleotides For The Treatment Of Hepatitis C Infection
#3646Method of treating a cancer by administering A 2′,5′-oligoadenylate analog
#3647Antisense modulation of connective tissue growth factor expression
#3648Production of functional proteins: balance of shear stress and gravity
#3649USE OF INHIBITORS OF LEUKOTRIENE B4 RECEPTOR BLT2 FOR TREATING ASTHMA
#3650Compositions and their uses directed to PTPR alpha
#3651OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITY
#3652METHOD OF DETECTING A CANCER CELL BY ABERRANT EXPRESSION OF A HUMAN K+ ION CHANNEL
#3653Compositions and methods for inhibiting expression of the MYC gene
#3654Short interfering ribonucleic acid (siRNA) with improved pharmacological properties
#3655Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene
#3656Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
#3657COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF CRP
#3658COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2
#3659ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#3660Compounds and methods for modulating expression of PTP1B
#3661Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3662Chimeric immunomodulatory compounds and methods of using the same-II
#3663Use of CSF-1 Inhibitors
#3664Compositions and their uses directed to IL-4R alpha
#3665RNAi modulation of ApoB and uses thereof
#3666METHODS TO TREAT OR PREVENT HORMONE-RESISTANT PROSTATE CANCER USING siRNA SPECIFIC FOR PROTOCADHERIN-PC, OR OTHER INHIBITORS OF PROTOCADHERIN-PC EXPRESSION OR ACTIVITY
#3667Compounds and methods for modulating expression of GCCR
#3668Compounds and methods for modulating expression ApoB
#3669Compounds and methods for modulating expression of GCGR
#3670CONJUGATED DOUBLE STRAND COMPOSITIONS FOR USE IN GENE MODULATION
#3671Compounds and methods for modulating expression of PCSK9
#3672Regulation of epigenetic control of gene expression
#3673Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3674MODULATION OF STAT 6 EXPRESSION
#3675COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF DGAT2
#3676Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3677Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3678Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
#3679Potent LNA oligonucleotides for the inhibition of HIF-1a expression
#3680Compositions and methods for delivering RNAI using lipoproteins
#3681Modulation of insulin like growth factor I receptor expression
#3682Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
#3683Compositions and Their Uses Directed to IL-4R Alpha
#3684Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
#3685RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
#3686Compositions and methods for inhibiting expression of XBP-1 gene
#3687THERAPEUTIC ANTISENSE OLIGONUCLEOTIDE COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
#3688Antisense modulation of C-reactive protein expression
#3689Compositions and methods for temperature-dependent nucleic acid synthesis
#3690MODULATION OF TUDOR-SN EXPRESSION
#3691HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF
#3692Means and method for inducing exon-skipping
#3693Kit for detection of telomerase reverse transcriptase nucleic acids
#3694Conjugates and compositions for cellular delivery
#3695Compositions and methods for inhibiting expression of factor VII gene
#3696DELIVERY OF POLYNUCLEOTIDE AGENTS TO THE CENTRAL NERVOUS SYSTEM
#3697CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
#3698Compositions and methods for inhibiting expression of Nav1.8 gene
#3699RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)
#3700RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3701PREVENTION OF VIRAL INFECTIVITY
#3702dsRNA compositions and methods for treating HPV infection
#3703RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3704Immunomodulatory agents and methods of use
#3705HEPATITIS C ANTIVIRALS
#3706RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3707Oligonucleotides stimulatory of the mesenchymal stem cell proliferation and uses thereof
#3708Induction of exon skipping in eukaryotic cells
#3709Modulation of the Transcription of Pro-Inflammatory Gene Products
#3710Oligomeric compounds and compositions for the use in modulation of microRNAs
#3711Compositions and methods for treatment of prostate and other cancers
#3712MODULATION OF LMW-PTPASE EXPRESSION
#3713Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone
#3714Oligonucleotides with alternating segments of locked and non-locked nucleotides
#3715Nucleic acid functionalized nanoparticles for therapeutic applications
#3716Direct Reversal Of The Suppressive Function Of CD4+Regulatory T Cells Via Toll-Like Receptor 8 Signaling
#3717COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE
#3718Compositions of asymmetric interfering RNA and uses thereof
#3719Suppressors of CpG oligonucleotides and methods of use
#3720MODULATION OF SURVIVIN EXPRESSION
#3721ANTISENSE COMPOUNDS HAVING ENHANCED ANTI-MICRORNA ACTIVITY
#3722HEPATITIS C ANTIVIRALS
#3723vWF aptamer formulations and methods for use
#3724Modulation of eIF4E-BP2 expression
#3725Compounds for the modulation of beta-catenin expression
#3726Glycoconjugates of RNA interference agents
#3727IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
#3728OLIGONUCLEOTIDES OR THEIR FUNCTIONAL HOMOLOGUES, A COMPOSITION COMPRISING THE SAME AND A METHOD OF TREATING B CELL NEOPLASM
#3729MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS
#37302'-Modified Oligonucleotides
#3731Interfering RNA duplex having blunt-ends and 3′-modifications
#3732RNA antagonist compounds for the modulation of PIK3CA expression
#3733Modulation of eIF4E expression
#3734RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)
#3735RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#3736Reducing Cancer Cell Invasion Using an Inhibitor of Toll Like Receptor Signaling
#3737Nucleic acid compositions and methods of introducing nucleic acids into cells
#3738MODULATION OF STAT 6 EXPRESSION FOR THE TREATMENT OF AIRWAY HYPERRESPONSIVENESS
#3739Constitutively active fragments of eukaryotic heat shock RNA
#3740LNA antagonists targeting the androgen receptor
#3741LNA oligonucleotides and the treatment of cancer
#3742METHOD OF TREATING NEURODEGENERATIVE DISEASE
#3743Complex for transferring an anionic substance into a cell
#3744Modulation of C-reactive protein expression
#3745Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)
#3746METHODS AND COMPOSITIONS FOR TREATING IMMUNE DISORDERS
#3747Novel siRNAS and methods of use thereof
#3748METHOD FOR PREVENTION OR TREATMENT OF DISEASES OR DISORDERS RELATED TO EXCESSIVE FORMATION OF VASCULAR TISSUE OR BLOOD VESSELS
#3749Oligonucleotide or its functional homologue, a composition comprising the same and a method of treating B cell neoplasm
#3750DBAIT and uses thereof
#3751Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field
#3752MODULATION OF ENDOTHELIAL LIPASE EXPRESSION
#3753RNAi inhibition of alpha-ENaC expression
#3754RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
#3755Antiviral oligonucleotides targeting viral families
#3756Novel siRNAS and methods of use thereof
#3757Polypeptide compounds for inhibiting angiogenesis and tumor growth
#3758Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics
#3759RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
#3760RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#3761Methods of Identifying Modulators of Interaction Between PDZ Domain Proteins and PL Proteins
#3762MicroRNAs
#3763Compositions and methods for inhibiting expression of a gene from the Ebola
#3764Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#3765Transcription factor decoy
#3766Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
#3767Semi-soft c-class immunostimulatory oligonucleotides
#3768RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3769RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
#3770RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)
#3771RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3772RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)
#3773METHOD OF DIAGNOSING COLON AND GASTRIC CANCERS
#3774Tripartite RNAi constructs
#3775Antisense modulation of PTP1B expression
#3776RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION
#3777Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of Cancer
#3778MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION
#3779Modulation of diacylglycerol acyltransferase 1 expression
#3780NUCLEIC ACIDS HYBRIDIZABLE TO MICRO RNA AND PRECURSORS THEREOF
#3781Antisense microRNA and uses therefor
#3782RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#3783RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3784RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)
#3785RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)
#3786Antiviral oligonucleotides
#3787RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)
#3788RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
#3789RNAi modulation of SCAP and therapeutics uses thereof
#3790TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS BY REVERSIBLE PHOSPHOTRIESTER CHARGE NEUTRALIZATION PROTECTING GROUPS
#3791Enhanced retinal delivery of a nucleic acid through iontophoresis
#3792Combination motif immune stimulatory oligonucleotides with improved activity
#3793Modulating Retinal Pigmented Epithelium Permeaion By Inhibiting Or Activating VEGFR-1
#3794Modulation of eIF4E-BP2 expression
#3795Modulation of transthyretin expression
#3796COMBINATIONS AND METHODS OF USING AN IMMUNOMODULATORY OLIGODEOXYNUCLEOTIDE
#3797Methods and compositions for the treatment of uveitis
#3798Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#3799Modulation of apolipoprotein (a) expression
#3800Metabolic profile directed aptamer medicinal chemistry
#3801Long term disease modification using immunostimulatory oligonucleotides
#3802Compositions and methods for inhibiting expression of a gene from the JC virus
#3803Compositions and methods for inhibiting expression of anti-apoptotic genes
#3804MODULATION OF SYNAPTOGENESIS
#3805Oligonucleotide modulation of cell adhesion
#3806Antiviral oligonucleotides targeting HBV
#3807Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions
#3808RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)
#3809RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#3810Double-Stranded Oligonucleotides
#3811Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease Therapeutics
#3812Antisense oligonucleotides for prevention of metastasis formation of cancer cells
#3813Dnazymes for Inhibition of Japanese Encephalitis Virus Replication
#3814COMPOUNDS FOR THE MODULATION OF BETA-CATENIN EXPRESSION
#3815Method for generating aptamers with improved off-rates
#3816RNA antagonist compounds for the modulation of HER3
#3817Antisense oligonucleotides against thymidylate synthase
#3818Method for modulating responsiveness to steroids
#3819Therapeutic uses of factors which inhibit or neutralize MIF activity
#3820Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer
#3821Isis Pharmaceuticals, Inc.
#3822Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins
#3823RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF
#3824MODULATION OF THE EXPRESSION OF STAT-1-DEPENDENT GENES
#3825Tandem siRNAS
#3826Synthetic agonists of TLR9
#3827Pharmaceutical Composition Containing Meltrin Antagonist
#3828Antisense oligonucleotides against cPLA, compositions and uses thereof
#3829Oligonucleotide complex compositions and methods of use as gene alteration tools
#3830Compositions and their uses directed to PTPRU
#3831Method for eliciting an immune response to human telomerase reverse transcriptase
#3832RNAi probes targeting cancer-related proteins
#3833Suppression of nuclear factor-κB dependent processes using oligonucleotides
#3834High viscosity macromolecular compositions for treating ocular conditions
#3835Preventives/Remedies for Cancer
#3836ANTISENSE OLIGONUCLEOTIDE STRATEGIES FOR THE ENHANCEMENT OF CANCER THERAPIES
#3837Compositions and methods for the modulation of JNK proteins
#3838RNA Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3839Modified Short Interfering Rna (Modified Sirna)
#3840Modified polynucleotides for reducing off-target effects in RNA interference
#3841Antisense modulation of apolipoprotein B expression
#3842Methods and compositions for the inhibition of HIV-1 replication
#3843Materials and methods for treatment of cancer
#3844Inhibitor Nucleic Acids
#3845Compositions and methods for inhibiting expression of Huntingtin gene
#3846Modulation of the Expression of Estrogen Receptors for the Prevention or Treatment of Heart Disease
#3847Aptamer-mediated intracellular delivery of oligonucleotides
#3848Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β)
#3849Histone deacetylase inhibitor and use thereof
#3850Induction of exon skipping in eukaryotic cells
#3851Decoy compositions for treating and preventing brain diseases and disorders
#3852Immunomodulatory polynucleotides and methods of using the same
#3853Compositions and methods for optimizing cleavage of RNA by RNase H
#3854Method For Preventing or Treating Pain in a Mammal
#3855Modulation of T cell signaling threshold and T cell sensitivity to antigens
#3856Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3857Antisense modulation of p38 mitogen activated protein kinase expression
#3858IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
#3859Oligomeric compounds for the modulation ras expression
#3860RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#3861ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION
#3862OLIGORIBONUCLEOTIDES FOR THE TREATMENT OF DEGENERATIVE SKIN CONDITIONS BY RNA INTERFERENCE
#3863Chimeric immunomodulatory compounds and methods of using the same
#3864Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
#3865COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#3866Modulation of FR-alpha expression
#3867Treatment of neurological disorders by dsRNA administration
#3868Modulation of forkhead box O1A expression
#3869Antisense modulation of stearoyl-CoA desaturase expression
#3870Methods of use of bcl-6-derived nucleotides to induce apoptosis
#3871Positionally modified siRNA constructs
#3872Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
#3873Clusterin antisense therapy for treatment of cancer
#3874Compositions and methods for inhibiting expression of the PCSK9 gene
#3875Compositions and methods for inhibiting expression of IKK-B gene
#3876COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA
#3877Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#3878Inhibitory oligonucleotides targeted to BCL-2
#3879Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
#3880Suppression of nuclear factor-κB dependent processes using oligonucleotides
#3881Multiple CpG oligodeoxynucleotides and their use to induce an immune response
#3882TRPM-2 antisense therapy
#3883G-rich polynucleotides as a novel therapeutic for the treatment of huntington's disease
#3884ANTISENSE OLIGONUCLEOTIDE MODULATION OF STAT3 EXPRESSION
#3885Opioid growth factor receptors
#3886Compositions and their uses directed to huntingtin
#3887RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS
#3888Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
#3889Polycationic compositions for cellular delivery of polynucleotides
#38902'-MODIFIED OLIGONUCLEOTIDES
#3891RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#3892Immunostimulatory nucleic acid molecules
#3893Immunostimulatory nucleic acid molecules
#3894Methods of treating, reducing, or preventing autoimmune conditions
#3895Antibodies to a human Kchannel and therapeutic applications thereof
#3896Short antisense compounds with gapmer configuration
#3897Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
#3898Antisense modulation of kinesin-like 1 expression
#3899Immunostimulatory oligonucleotides
#3900BACKBONE MODIFICATIONS TO MODULATE OLIGONUCLEOTIDE TARGETING IN VIVO